Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
134studies shown
Showing 76-100 of 134
RecruitingNCT05074901

Virtual Agents-based Digital Interventions to Improve Health

This study is looking at whether a digital support tool can help people with depression or anxiety. Participants take part in the program and complete follow-up questionnaires or assessments.

DepressionBehavioralOver 18 Years
Countries
France
Sponsor
University of Bordeaux
Condition
Depression
RecruitingISRCTN37471300

Gender bias in the pharmacological management of pain, anxiety, and depression in general practice

This observational study is following people with Pharmacological management of pain, anxiety, and depression in general practice or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionOtherFrom 18 Years to 100 Years
Countries
France
Sponsor
Inserm
Condition
Depression
RecruitingISRCTN99520723

Sex differences in interoception and mental health: an investigation across the menstrual cycle

This observational study is following people with Identifying sex differences in interoception, common mental health disorders and mood, and somatic complaints, and identifying whether the menstrual cycle may contribute to these differences or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

AnxietyOtherFrom 18 Years to 40 Years
Countries
United Kingdom, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Sponsor
University of Surrey
Condition
Anxiety
RecruitingISRCTN83632872

Child resilience in Afghanistan study

This observational study is following people with Anxiety and depression or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

AnxietyOtherFrom 8 Years to 14 Years
Countries
Afghanistan, France
Sponsor
Washington University in St. Louis
Condition
Anxiety
RecruitingISRCTN12329547

Trial of a digital depression management application: juli

This study is looking at whether a digital support tool can help people with Depression, Mental and Behavioural Disorders, or Depressive episode, unspecified. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 18 Years to 65 Years
Countries
United Kingdom, Afghanistan, Finland, Albania, Algeria, United States, Andorra, Angola, Antarctica, Antigua and Barbuda, Argentina, Armenia, Netherlands, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Norway, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo, Congo, Democratic Republic, New Zealand, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Côte d'Ivoire, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini, Ethiopia, Fiji, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Vatican City, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, South Korea, Kosovo, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Federated States of, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Nicaragua, Niger, Nigeria, North Macedonia, Oman, Pakistan, Palau, Palestine, State of, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkmenistan, Tuvalu, Turkey, Uganda, Ukraine, United Arab Emirates, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Western Sahara, Yemen, Zambia, Zimbabwe
Sponsor
University College London
Condition
Depression
RecruitingISRCTN73157235

Effects of a prenatal program group led to parental couples to prevent postpartum depression in women of middle and lower classes living in northern Catalonia and Southern France [Effetsd’unprogrammeprénatal de groupeadresséauxcouplesparentauxpourprévenir la dépressionpostnatale des femmes de clases moyenne et défavoriséehabitant en Catalogne Nord et en France Sud]

This study is looking at whether a digital support tool can help people with Postpartum depression, Mental and Behavioural Disorders, or Mental and behavioural disorders associated with the puerperium, not elsewhere classified. Participants take part in a digital support tool and complete follow-up assessments.

DepressionOther
Countries
France, Spain
Sponsor
ADERMNCN (Association for better childbirth in Northern Catalonia) (Spain)
Condition
Depression
RecruitingISRCTN44737909

Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in patients with major depressive disorder: a six-week randomised, double-blind parallel group study versus comparator, followed by a double-blind optional treatment extension period up to six months

This study is looking at whether Therapeutic doses of agomelatine versus therapeutic doses of SSRI can help people with depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherOver 18 Years
Countries
United Kingdom, Australia, Austria, Brazil, Finland, France, Germany, Spain, Taiwan
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
RecruitingISRCTN49376288

Efficacy of agomelatine given orally on rest/activity circadian rhythms in outpatients with major depressive disorder: a randomised, double-blind international study with parallel groups versus Selective Serotonin Reuptake Inhibitor (SSRI). Six-week treatment plus optional continuation for 18 weeks.

This study is looking at care and outcomes for people with depression or Mental and Behavioural Disorders. Taking part may give some people access to Agomelatine versus SSRI, but direct benefit is not guaranteed.

DepressionOtherFrom 18 Years to 60 Years
Countries
Austria, France, Germany, Italy, Poland, Spain
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
RecruitingISRCTN28588282

Efficacy and safety of agomelatine given orally compared to placebo, in addition to a mood stabiliser in bipolar I patients with a current major depressive episode. An eight week randomised, double-blind, controlled, parallel group study followed by a double-blind extension treatment period up to one year

This study is looking at care and outcomes for people with Major depressive episode, Mental and Behavioural Disorders, or Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

DepressionOtherOver 18 Years
Countries
France
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Depression
OngoingEUCTR 2009-014056-30

Reconnaissance des expressons faciales émotionnelles chez les patients présentant un épisode dépressif magnétique transcranienne répétée du cortex préfrontal dorsolatéral droit à basse fréquence et...

This study is looking at whether Venlafaxine can help people with depression or Elderly. Participants receive the study medicine Venlafaxine and complete study visits and assessments.

DepressionOther
Countries
France
Sponsor
CHU Clermont-Ferrand
Condition
Depression
OngoingEUCTR 2022-000430-42

An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study is looking at whether Aticaprant can help people with depression or Elderly. Participants receive the study medicine Aticaprant and complete study visits and assessments.

DepressionOther
Countries
Sweden, Hungary, Belgium, Czech Republic, Poland, Bulgaria, France, Spain, Portugal, Slovakia
Sponsor
Janssen-Cilag International NV
Condition
Depression
CompletedEUCTR 2008-005353-38

Interventional, randomised, double-blind, placebo-controlled, active reference (fluoxetine), fixed-dose study of vortioxetine in paediatric patients aged 7 to 11 years, with Major depressive disord...

This study is comparing VORTIOXETINE with Fluoxetine for people with depression or Children, Under 18. Participants receive VORTIOXETINE or Fluoxetine and complete study visits and assessments.

DepressionOther
Countries
Latvia, Estonia, United Kingdom, Hungary, Finland, Germany, Italy, Spain, Bulgaria, Poland, France, View results
Sponsor
H. Lundbeck A/S
Condition
Depression
CompletedEUCTR 2019-001989-15

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Extension to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of...

This study is comparing fremanezumab with placebo for people with Migraine and depression or Elderly. Participants receive fremanezumab or placebo and complete study visits and assessments.

DepressionOther
Countries
Germany, Czech Republic, France, Finland, Greece, Spain, Italy, View results
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Depression
CompletedNCT04436757

Self and Body-esteem in Socio-professional Rehabilitation

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Depression
CompletedNCT05650788

Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 40 Years
Countries
France
Sponsor
University Hospital, Clermont-Ferrand
Condition
Bipolarity
CompletedNCT05603819

Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolarity, Based on RNA Editing Blood Biomarkers

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

BipolarityOtherFrom 18 Years to 80 Years
Countries
Denmark, France, Spain
Sponsor
Alcediag
Condition
Bipolarity
CompletedNCT05965232

FIbrosis and Steatosis in Patients With Psychiatric Illness

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

BipolarityOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Esquirol
Condition
Bipolarity
CompletedNCT01644747

tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Besancon
Condition
Bipolarity
CompletedNCT01973478

Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 70 Years
Countries
France
Sponsor
Rennes University Hospital
Condition
Depression
CompletedNCT01914393

Pediatric Open-Label Extension Study

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 6 Years to 17 Years
Countries
Bulgaria, Colombia, France, Hungary, Malaysia, Mexico, Philippines, Poland, United States, Romania, Russian Federation, South Korea, Spain, Ukraine
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia